Occupational allergy to glucagon-like peptide-1 receptor agonist precurser

被引：0
|
作者：
Johnsen, C. R. [1 ]
Rudkjoebing, L. A. [2 ]
Bartko, E. [3 ]
机构：
[1] Gentofte Univ Hosp, Hellerup, Denmark
[2] Holbaek Cent Hosp, Holbaek, Denmark
[3] Allergy Clin, Dermatol & Allergy, Hellerup, Denmark
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
100324
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes
    Goralska, Joanna
    Sliwa, Agnieszka
    Gruca, Anna
    Razny, Urszula
    Chojnacka, Monika
    Polus, Anna
    Solnica, Bogdan
    Malczewska-Malec, Malgorzata
    ACTA BIOCHIMICA POLONICA, 2017, 64 (03) : 423 - 429
  • [32] A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
    Griffith, David A.
    Edmonds, David J.
    Fortin, Jean-Philippe
    Kalgutkar, Amit S.
    Kuzmiski, J. Brent
    Loria, Paula M.
    Saxena, Aditi R.
    Bagley, Scott W.
    Buckeridge, Clare
    Curto, John M.
    Derksen, David R.
    Dias, Joao M.
    Griffor, Matthew C.
    Han, Seungil
    Jackson, V. Margaret
    Landis, Margaret S.
    Lettiere, Daniel
    Limberakis, Chris
    Liu, Yuhang
    Mathiowetz, Alan M.
    Patel, Jayesh C.
    Piotrowski, David W.
    Price, David A.
    Ruggeri, Roger B.
    Tess, David A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (12) : 8208 - 8226
  • [33] The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
    Zhao, Li
    Zhu, Chunfang
    Lu, Meng
    Chen, Chi
    Nie, Xiaomin
    Abudukerimu, Buatikamu
    Zhang, Kun
    Ning, Zhiyuan
    Chen, Yi
    Cheng, Jing
    Xia, Fangzhen
    Wang, Ningjian
    Jensen, Michael D.
    Lu, Yingli
    JOURNAL OF ENDOCRINOLOGY, 2019, 240 (02) : 271 - 286
  • [34] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    A. Faurschou
    F. K. Knop
    J. P. Thyssen
    C. Zachariae
    L. Skov
    T. Vilsbøll
    Acta Diabetologica, 2014, 51 : 147 - 150
  • [35] Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2023, 15 (09) : 712 - 713
  • [36] Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide-1 Receptor Agonist
    Bucheit, John D.
    Pamulapati, Lauren G.
    Carter, Nicole
    Malloy, Kevin
    Dixon, Dave L.
    Sisson, Evan M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (01) : 10 - 18
  • [37] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    Faurschou, A.
    Knop, F. K.
    Thyssen, J. P.
    Zachariae, C.
    Skov, L.
    Vilsboll, T.
    ACTA DIABETOLOGICA, 2014, 51 (01) : 147 - 150
  • [38] Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
    Kobori, Toshiko
    Onishi, Yukiko
    Yoshida, Yoko
    Tahara, Tazu
    Kikuchi, Takako
    Kubota, Tetsuya
    Iwamoto, Masahiko
    Sawada, Tomonobu
    Kobayashi, Reo
    Fujiwara, Hiroaki
    Kasuga, Masato
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (06) : 767 - 773
  • [39] Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy
    Hong, Yeonhee
    Lee, Jong Han
    Jeong, Kwang Won
    Choi, Cheol Soo
    Jun, Hee-Sook
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (04) : 903 - 918
  • [40] Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
    Van Schaik, Jiska
    Begijn, Dominique G. A.
    Van Iersel, Laura
    Vergeer, Yvonne
    Hoving, Eelco W.
    Peeters, Babette
    Van Santen, Hanneke M.
    OBESITY FACTS, 2020, 13 (04) : 361 - 370
12345